Naoki Terasaka

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 8

Top Topics

Atrial Fibrillation

Systematic Review

Ejection Fraction

Top Venues

Cardiology and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Masahiro Yasaka, Michiyasu Suzuki, Shigeki Kushimoto, Ayako Kiyonaga, Antoinette Mangione, Yuki Niwa, Naoki Terasaka
Real-World Safety and Effectiveness of a 4-Factor Prothrombin Complex Concentrate in Japanese Patients Experiencing Major Bleeding: A Post-marketing Surveillance Study. Cardiology and therapy 13 (1) (2024)
Masahiro Yasaka, Fumihiko Shimizu, Yuki Niwa, Ayako Kiyonaga, Naoki Terasaka
Safety and Effectiveness of Four-Factor Prothrombin Complex Concentrate in Special Populations with INR Below 2: A Post-Marketing Surveillance Study. Cardiology and therapy 13 (3) (2024)
Masahiro Yasaka, Fumihiko Shimizu, Yuki Niwa, Ayako Kiyonaga, Naoki Terasaka
Safety and Effectiveness of Four-Factor Prothrombin Complex Concentrate in Special Populations with INR Below 2: A Post-Marketing Surveillance Study. Cardiology and therapy (2024)
Masahiro Yasaka, Michiyasu Suzuki, Shigeki Kushimoto, Ayako Kiyonaga, Antoinette Mangione, Yuki Niwa, Naoki Terasaka
Real-World Safety and Effectiveness of a 4-Factor Prothrombin Complex Concentrate in Japanese Patients Experiencing Major Bleeding: A Post-marketing Surveillance Study. Cardiology and therapy 13 (1) (2024)
Masahiro Yasaka, Fumihiko Shimizu, Yuki Niwa, Ayako Kiyonaga, Naoki Terasaka
Safety and Effectiveness of Four-Factor Prothrombin Complex Concentrate in Special Populations with INR Below 2: A Post-Marketing Surveillance Study. Cardiology and therapy 13 (3) (2024)
Masahiro Yasaka, Michiyasu Suzuki, Shigeki Kushimoto, Ayako Kiyonaga, Antoinette Mangione, Yuki Niwa, Naoki Terasaka
Real-World Safety and Effectiveness of a 4-Factor Prothrombin Complex Concentrate in Japanese Patients Experiencing Major Bleeding: A Post-marketing Surveillance Study. Cardiology and therapy 13 (1) (2024)
Masahiro Yasaka, Fumihiko Shimizu, Yuki Niwa, Ayako Kiyonaga, Naoki Terasaka
Safety and Effectiveness of Four-Factor Prothrombin Complex Concentrate in Special Populations with INR Below 2: A Post-Marketing Surveillance Study. Cardiology and therapy 13 (3) (2024)
Masahiro Yasaka, Michiyasu Suzuki, Shigeki Kushimoto, Ayako Kiyonaga, Antoinette Mangione, Yuki Niwa, Naoki Terasaka
Real-World Safety and Effectiveness of a 4-Factor Prothrombin Complex Concentrate in Japanese Patients Experiencing Major Bleeding: A Post-marketing Surveillance Study. Cardiology and therapy (2024)